Arcus Biosciences, Inc. (RCUS) Analyst Forecast

$0.00

$0 (0%)
Last update: 07:00 PM EST
Day's range
$21.43
Day's range
$23.49

Recent Analyst Forecasts and Stock Ratings

Date Brokerage Firm Analyst Name Price Target Price when Posted Upside/Downside
on Report Date
Details
01/12/2026 Goldman Sachs Richard Law $28.00 $21.30   31.46%
10/30/2025 Goldman Sachs Salveen Richter $16.00 $20.64   -22.48%
10/07/2025 Truist Financial Asthika Goonewardene $39.00 $14.48   169.34%
05/07/2025 Wells Fargo Eva Fortea Verdejo $26.00 $8.12   220.2%
10/24/2024 Citigroup Yigal Nochomovitz $46.00 $17.42   164.14%
10/21/2024 H.C. Wainwright Emily Bodnar $20.00 $18.44   8.46%
10/08/2024 Wells Fargo Eva Fortea Verdejo $29.00 $18.08   60.4%
10/08/2024 Morgan Stanley Judah Frommer $35.00 $18.08   93.58%
08/09/2024 Bank of America Securities Jason Zemansky $23.00 $13.69   68.01%
07/08/2024 Barclays Peter Lawson $25.00 $14.00   78.57%
06/24/2024 Truist Financial Asthika Goonewardene $44.00 $16.45   167.48%
06/04/2024 Barclays Peter Lawson $35.00 $16.15   116.72%
05/11/2022 Wedbush Robert Driscoll $42.00 $24.01   74.93%

Arcus Biosciences Inc FAQ's

Arcus Biosciences Inc has been rated by research analysts at Leerink Partners, Wells Fargo, Goldman Sachs, Morgan Stanley, Truist Financial, H.C. Wainwright in the past 90 days.